The Patient Voice Initiative invites patient groups and communities to join us for this three-part webinar series on patient-based evidence. In this webinar, we’ll focus on answering your questions about Patient Reported Outcome Measures (PROMs) research for reimbursement decisions in Australia, especially PBAC and MSAC.

Including:

• What is PROMS research and what can it do? (Prof Rachel Morton, The University of Sydney)
• How and why NeuroEndocrine Cancer Australia uses PROMs research (Simone Leyden, NeuroEndocrine Cancer Australia. CEO)
• Time for your questions

This webinar is provided for free, thanks to the following sponsorship of the Patient Voice Initiative:

Gold Sponsors: Bristol-Myers Squibb; Lilly; Sanofi

Silver Sponsors: Astra Zeneca; Biogen; Janssen; MSD; Pfizer; Medicines Australia; Shire/Takeda

Ongoing inkind support: CaPPRe; Rare Cancers Australia

And the generosity of all speakers who have given their time for free.